This Article Full Text Full Text (PDF) All Versions of this Article: 146/10/4217    most recent Author Manuscript (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ida, T. Articles by Murakami, N. Search for Related Content PubMed PubMed Citation Articles by Ida, T. Articles by Murakami, N.

Neuromedin S Is a Novel Anorexigenic Hormone

Department of Veterinary Physiology (T.I., Y.E., S.A., K.N., N.M.), Faculty of Agriculture, University of Miyazaki, Miyazaki 889-2155; Department of Biochemistry (K.M., M.M., K.K.), National Cardiovascular Center Research Institute, Fujishirodai, Suita, Osaka 565-8565; and Laboratory of Veterinary Physiology (M.N.), Veterinary Medical Science, The University of Tokyo, Tokyo 113-8657, Japan

Address all correspondence and requests for reprints to: Noboru Murakami, Ph.D., Department of Veterinary Physiology, Faculty of Agriculture University of Miyazaki, Miyazaki 889-2155, Japan. E-mail: a0d201u{at}cc.miyazaki-u.ac.jp.

A novel 36-amino acid neuropeptide, neuromedin S (NMS), has recently been identified in rat brain and has been shown to be an endogenous ligand for two orphan G protein-coupled receptors, FM-3/GPR66 and FM-4/TGR-1. These receptors have been identified as neuromedin U (NMU) receptor type 1 and type 2, respectively. In this study, the physiological role of the novel peptide, NMS, on feeding regulation was investigated. Intracerebroventricular (icv) injection of NMS decreased 12-h food intake during the dark period in rats. This anorexigenic effect was more potent and persistent than that observed with the same dose of NMU. Neuropeptide Y, ghrelin, and agouti-related protein-induced food intake was counteracted by coadministration of NMS. Icv administration of NMS increased proopiomelanocortin mRNA expression in the arcuate nucleus (Arc) and CRH mRNA in the paraventricular nucleus (PVN). Pretreatment with SHU9119 (antagonist for -MSH) and -helical corticotropin-releasing factor-(9–41) (antagonist for CRH) attenuated NMS-induced suppression of 24-h food intake. After icv injection of NMS, Fos-immunoreactive cells were detected in both the PVN and Arc. When neuronal multiple unit activity was recorded in the PVN before and after icv injection of NMS, a significant increase in firing rate was observed 5 min after administration, and this increase continued for 100 min. These results suggest that the novel peptide, NMS, may be a potent anorexigenic hormone in the hypothalamus, and that expression of proopiomelanocortin mRNA in the Arc and CRH mRNA in the PVN may be involved in NMS action on feeding.

This article has been cited by other articles:

				E. Vigo, J. Roa, R. Pineda, J. M. Castellano, V. M. Navarro, E. Aguilar, L. Pinilla, and M. Tena-Sempere Novel role of the anorexigenic peptide neuromedin U in the control of LH secretion and its regulation by gonadal hormones and photoperiod Am J Physiol Endocrinol Metab, November 1, 2007; 293(5): E1265 - E1273. [Abstract] [Full Text] [PDF]

				C. Melcher, R. Bader, and M. J Pankratz Amino acids, taste circuits, and feeding behavior in Drosophila: towards understanding the psychology of feeding in flies and man J. Endocrinol., March 1, 2007; 192(3): 467 - 472. [Abstract] [Full Text] [PDF]

				E. Vigo, J. Roa, M. Lopez, J. M. Castellano, R. Fernandez-Fernandez, V. M. Navarro, R. Pineda, E. Aguilar, C. Dieguez, L. Pinilla, et al. Neuromedin S as Novel Putative Regulator of Luteinizing Hormone Secretion Endocrinology, February 1, 2007; 148(2): 813 - 823. [Abstract] [Full Text] [PDF]